Retrieved
The first batch of the Sputnik V vaccine against the novel coronavirus, developed by the Russian research institution Gamaleya Research Institute of Epidemiology and Microbiology, arrived in Venezuela to start phase three of clinical trials on 2,000 local patients. By Diego Marcano. Full Text -> PulitzerCenter
More Stories
Los retos que tendrá el próximo presidente de Venezuela
Biden’s New Order to Halt Asylum at the US Border
How to get Venezuela out of its cycle of conflict.